Analyst Price Targets — MRNA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 17, 2026 2:22 pm | Luca Issi | RBC Capital | $30.00 | $42.54 | TheFly | Moderna price target raised to $30 from $25 at RBC Capital |
| February 17, 2026 12:48 pm | Cory Kasimov | Evercore ISI | $35.00 | $43.19 | TheFly | Moderna price target raised to $35 from $28 at Evercore ISI |
| February 17, 2026 12:04 pm | — | Bernstein | $45.00 | $42.23 | TheFly | Moderna price target raised to $45 from $35 at Bernstein |
| February 16, 2026 12:52 pm | — | UBS | $36.00 | $42.23 | TheFly | Moderna price target raised to $36 from $34 at UBS |
| February 16, 2026 12:47 pm | — | Morgan Stanley | $30.00 | $42.23 | TheFly | Moderna price target raised to $30 from $28 at Morgan Stanley |
| January 6, 2026 9:28 pm | — | UBS | $34.00 | $35.66 | TheFly | Moderna assumed at Neutral from Buy at UBS |
| December 12, 2025 1:11 pm | — | Morgan Stanley | $28.00 | $29.90 | TheFly | Moderna price target lowered to $28 from $30 at Morgan Stanley |
| December 12, 2025 12:59 am | — | Jefferies | $30.00 | $29.62 | TheFly | Moderna initiated with a Hold at Jefferies |
| November 21, 2025 1:04 pm | Luca Issi | RBC Capital | $25.00 | $23.10 | TheFly | Moderna price target lowered to $25 from $28 at RBC Capital |
| November 21, 2025 12:42 pm | — | UBS | $18.00 | $22.36 | TheFly | Moderna price target raised to $18 from $15 at Leerink |
Latest News for MRNA
Moderna ( MRNA ) stock has shed roughly 90% of its value since its 2021 peak. When I wrote about the Moderna stock setup last week, shares sat around $50.
Moderna jumps 4% after EU panel backs mCombriax, its COVID-19-flu combo shot, with phase III data showing stronger immune response vs standalone vaccines.
If you purchase a 10-year U.S. Treasury bond, you'll get an annual yield of around 4%.
Banco Santander S.A. raised its stake in Moderna, Inc. (NASDAQ: MRNA) by 22.1% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 215,894 shares of the company's stock after buying an additional 39,056 shares during the period. Banco Santander S.A. owned approximately 0.06%
The recommendation from regulators paves the way for the shot's approval in the European Union at a time the company is facing scrutiny in the U.S.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MRNA.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.